Back to results
US 2012/0230997 A1Published application
Anti-factor B antibodies and their uses
OwnerMenno Van Lookeren Campagne, Laura Deforgeinventors
Life of this patent
Estimating the term…
Abstract
The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of factor B antagonists.
Claims16
A method for the prevention or treatment of a complement-associated eye condition comprising administering to a subject in need an effective amount of a factor B antagonist.
Dependencies are inferred from the claim text.